On Friday, Shares of Textron Inc. (NYSE:TXT), lost -0.71% to $46.14.
Textron Inc., declared plans to move forward with a letter of intent (LOI) to acquire 20 Bell 525 Relentless helicopters. These aircraft will serve a variety of roles with Milestone’s lessees around the world, counting oil and gas, emergency medical service, search and rescue, and utility opportunities. Delivery of aircraft to Milestone is predictable to start in late 2017.
“We are very happy to declare our first order with Bell Helicopter,” said Milestone’s Chairman, Richard Santulli. “With the 525, our customers will benefit from the newest fly-by-wire technology and its mission versatility.”
Textron Inc. operates in the aircraft, defense, industrial, and finance businesses worldwide. It operates through five segments: Textron Aviation, Bell, Textron Systems, Industrial, and Finance.
Shares of Agilent Technologies Inc (NYSE:A), declined -1.03% to $39.49, during its last trading session.
Agilent Technologies Inc., declared that Dr. Arturo Keller has received an Agilent Thought Leader Award in support of his research on the use of nano-particles in agriculture and the environmental consequences.
Dr. Keller, who directs the Center for the Environmental Implications of Nanotechnology at the University of California, Santa Barbara, has earned international recognition for his research into the uptake, accumulation and biotransformation of nano-particles in natural waters and soil. By collaborating with Dr. Keller, Agilent intends to catalyze the development of new analytical methods to better understand both the efficacy and environmental impact of emerging nano-particle delivery methods for fertilizers, nutrients, pesticides and herbicides.
Agilent Technologies, Inc. provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide.
At the end of Friday’s trade, Shares of Omega Healthcare Investors Inc (NYSE:OHI), lost -0.44% to $36.32.
Omega Healthcare Investors, Inc., declared the commencement of an offer to exchange $250 million of its 4.50% Senior Notes due 2025 that have been registered under the Securities Act of 1933 for $250 million of its outstanding 4.50% Senior Notes due 2025, which were issued on September 11, 2014 in a private placement. The exchange offer is being conducted upon the terms and subject to the conditions set forth in the prospectus dated June 17, 2015, and the related letter of transmittal.
The Exchange Notes are identical in all material respects to the Initial Notes, except that the Exchange Notes will be registered under the Securities Act of 1933 and the provisions of the Initial Notes relating to transfer restrictions, registration rights and additional interest will not apply to the Exchange Notes.
Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. was founded in 1992 and is based in Maryland, United States.
Finally, Warren Resources, Inc. (NASDAQ:WRES), ended its last trade with -6.60% loss, and close at $0.503.
Warren Resources, Inc., declared that it will present at the Global Hunter Securities 100 Energy Conference at the JW Marriott in Chicago, Illinois on Tuesday, June 23, 2015 at 8:30 a.m. (CDT). Senior administration counting interim Chief Executive Officer Lance Peterson and Vice President and Chief Financial Officer Stewart P. Skelly will talk about the Company’s strategy, development plans and outlook.
Warren Resources, Inc., an independent energy company, engages in the exploration, development, and production of domestic onshore crude oil and gas reserves.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
